Tags:DevelopmentDrugMedtech
Tisbury Pharmaceutical Inc (Tisbury Pharmaceuticals BV). is a pharmaceutical company developing a first-in-class drug to treat glaucoma. Its primary development target is patients with open angle glaucoma and ocular hypertension patients.
Location: United States, Massachusetts, Beverly
Member count: 11-50
Total raised: $32M
Founded date: 2017

Investors 1

DateNameWebsite
19.02.2021HealthCaphealthcap....

Funding Rounds 1

DateSeriesAmountInvestorsDeal News
16.06.2017Series A$32M-healthcap....

Mentions in press and media 2

DateTitleDescriptionCategoryAuthorSource
16.06.2017Tisbury Ph...Tisbury Pharmaceuticals, Inc.,...USA-finsmes.co...
-Tisbury Ph...Boston, Massachusetts (PRWEB) ...--healthcap....